Antithrombin III for critically ill patients
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Antithrombin III for critically ill patients. / Afshari, Arash; Wetterslev, Jørn; Brok, Jesper Sune; Møller, Ann Merete.
In: Cochrane Database of Systematic Reviews, No. 3, 01.01.2008, p. CD005370.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Antithrombin III for critically ill patients
AU - Afshari, Arash
AU - Wetterslev, Jørn
AU - Brok, Jesper Sune
AU - Møller, Ann Merete
N1 - Times Cited: 0ReviewEnglishAfshari, AUniv Copenhagen, Rigshosp, Dept Paediat & Obstet Anaesthesiol, Blegdamsvej 9, DK-2100 Copenhagen O, DenmarkCited References Count: 87328PSJOHN WILEY & SONS LTDTHE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLANDCHICHESTER
PY - 2008/1/1
Y1 - 2008/1/1
N2 - Critical illness is associated with uncontrolled inflammation and vascular damage which can result in multiple organ failure and death. Antithrombin III (AT III) is an anticoagulant with anti-inflammatory properties but the efficacy and any harmful effects of AT III supplementation in critically ill patients are unknown.
AB - Critical illness is associated with uncontrolled inflammation and vascular damage which can result in multiple organ failure and death. Antithrombin III (AT III) is an anticoagulant with anti-inflammatory properties but the efficacy and any harmful effects of AT III supplementation in critically ill patients are unknown.
U2 - 10.1002/14651858.CD005370.pub2
DO - 10.1002/14651858.CD005370.pub2
M3 - Journal article
C2 - 18646125
SP - CD005370
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
SN - 1361-6137
IS - 3
ER -
ID: 10245834